Neurology is viewed as a therapeutic category with a considerable market opportunity given the limited progress over the years in both neurodegenerative and psychiatric diseases. It is well known that Alzheimer’s disease remains a focal point for larger

Neurology is viewed as a therapeutic category with a considerable market opportunity given the limited progress over the years in both neurodegenerative and psychiatric diseases. It is well known that Alzheimer’s disease remains a focal point for larger biopharmas $IBB $SAGE

More From BioPortfolio on "Neurology is viewed as a therapeutic category with a considerable market opportunity given the limited progress over the years in both neurodegenerative and psychiatric diseases. It is well known that Alzheimer’s disease remains a focal point for larger"